Related Experiment Video
Updated: Sep 7, 2025

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
A Term Infant Presenting with COVID-19 Disease at Birth and a Croup-Like Cough
Michelle Arnold1,2,3, Christine Wade3,4, Becky Micetic3,4
1College of Medicine, University of Arizona College of Medicine, Phoenix, Arizona.
Insights
A newborn infant contracted COVID-19 at birth and developed a persistent, croup-like cough. Standard respiratory treatments were ineffective, necessitating prolonged hospitalization and intensive care. This case highlights unique COVID-19 presentations in neonates.
Area of Science:
- Neonatology
- Pediatric Infectious Diseases
- Virology
Background:
- The novel coronavirus disease 2019 (COVID-19) has been associated with various symptoms in children, including croup-like coughs.
- Information regarding COVID-19 in newborn infants, particularly concerning vertical transmission, remains limited, with vertical transmission considered rare.
- This case report focuses on a term newborn diagnosed with COVID-19 at birth.
Observation:
- A term infant diagnosed with COVID-19 at birth experienced respiratory distress, requiring transfer to the neonatal intensive care unit.
- The infant necessitated endotracheal intubation on day of life 7 due to escalating respiratory support needs.
- Following extubation on day of life 21, the infant developed a persistent croup-like cough.
Findings:
- Despite comprehensive respiratory treatments including albuterol, budesonide, racemic epinephrine, lidocaine, dornase alfa, and a 10-day course of dexamethasone, the croup-like cough did not resolve.
- The infant required an extended hospitalization period, ultimately being discharged on day of life 95 with supplemental oxygen support.
- This case underscores a complicated clinical course for a neonate with congenital COVID-19 infection.
Implications:
- The evolving nature of the COVID-19 virus can lead to diverse clinical presentations in both pediatric and adult populations.
- Increased provider vigilance and rapid dissemination of new findings are crucial for effectively managing infants diagnosed with COVID-19.
- This case highlights the potential for severe respiratory complications, including croup-like symptoms, in neonates with COVID-19, emphasizing the need for tailored treatment strategies.
Objective:
Since the global outbreak of the novel coronavirus disease 2019 (COVID-19), there have been increasing reports of children developing a croup-like cough associated with concurrent COVID-19 infection. Currently, there is not much information available regarding newborn infants and COVID-19 infection and the incidence of vertical transmission is thought to be rare. This novel case report depicts a term newborn infected at the time of birth with COVID-19 and includes details about the course of their complicated hospitalization.
Study Design:
A term infant, found to be infected at birth with COVID-19, developed respiratory distress resulting in transfer to our neonatal intensive care unit. Due to the increasing respiratory support requirements, endotracheal intubation was required on day of life (DOL) 7. Later, when the infant was extubated, on DOL 21, a croup-like cough developed.
Results:
Despite respiratory treatment with albuterol, budesonide, racemic epinephrine, lidocaine, dornase alfa, and a 10-day course of dexamethasone, the cough persisted. A prolonged hospitalization was required and eventually the infant was discharged home on 0.4 L/minute of oxygen via nasal cannula on DOL 95.
Conclusion:
As the COVID-19 virus mutates over time, there are some seemingly different presentations in both the pediatric and adult populations. The hypervigilance and sharing of new findings among providers are paramount in the treatment of infants with COVID-19 disease.
Key Points:
· Term infant with COVID-19 developed a croup-like cough.. · Usual respiratory treatment not effective with croup-like cough and COVID-19.. · COVID-19 present at birth later requiring intubation..
Related Concept Videos
Pulmonary Cycle: Exhalation
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Pneumonia II: Pathophysiology
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Breathing
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

